Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord-derived mesenchymal stem cells (Yuanpin Biotech)
- Development stage
- Preclinical
- Lead developer
- Yuanpin Biotech
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Yuanpin Biotech is developing an umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy for the treatment of Acute Respiratory Distress Syndrome (ARDS). This cell-based biologic is designed to be administered via injection, likely intravenously, to target lung inflammation. The therapy leverages the innate properties of UC-MSCs, which include immunomodulatory, anti-inflammatory, and tissue-regenerative effects. By modulating the immune response and promoting the repair of damaged lung tissue, the therapy aims to alleviate the severe respiratory failure associated with ARDS. Yuanpin Biotech has submitted a clinical trial application for this product in China, specifically targeting patients with mild to moderate ARDS.
- Other names
- Human Umbilical Cord Mesenchymal Stem Cell InjectionUmbilical Cord MSC for ARDS
Beyond the preview
Go deeper on umbilical cord-derived mesenchymal stem cells (Yuanpin Biotech).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord-derived mesenchymal stem cells (Yuanpin Biotech).